Grantham, Mayo, Van Otterloo & Co (GMO)’s Barclays BCS Stock Holding History
Bought
Maintained
Sold
Other funds holding BCS
Grantham, Mayo, Van Otterloo & Co (GMO)'s BCS Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Barclays (BCS) stake by 53% in Q2 2026, selling an estimated $265K and leaving 9,746 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #617.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BCS in Q2 2021 and has held it in 13 quarters since. The position peaked at $16.5M in Q3 2023. 557 funds tracked by Wall St. Rank hold BCS as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 9,746 shares of Barclays worth $262K as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,000 Barclays shares in Q2 2026, an estimated $265K.
- Barclays made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #617 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Barclays in Q2 2021 and has held it in 13 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Barclays position peaked at $16.5M in Q3 2023.
- 557 funds tracked by Wall St. Rank held Barclays as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.